Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers.

Luo, Jia; Rizvi, Hira; Egger, Jacklynn V; Preeshagul, Isabel R; Wolchok, Jedd D; Hellmann, Matthew D

Luo, Jia; Rizvi, Hira; Egger, Jacklynn V; Preeshagul, Isabel R; Wolchok, Jedd D; Hellmann, Matthew D.

Affiliation

Luo J; Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Rizvi H; Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Egger JV; Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Preeshagul IR; Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Wolchok JD; Department of Medicine, Weill Cornell Medical Center, New York, New York.
Hellmann MD; Human Oncology and Pathogenesis Program, Department of Medicine and Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, New York.

Cancer Discov ; 10(8): 1121-1128, 2020 08.

Article de En | MEDLINE | ID: mdl-32398243

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pneumopathie virale / Infections à coronavirus / Coronavirus / Pandémies / Tumeurs du poumon Limites: Humans Langue: En Journal: Cancer Discov Année: 2020 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google